The effects of type 2 diabetes and hypertension on changes in serum prostate specific antigen levels: Results from the olmsted county study

Urology

Volumn 77, Issue 1, 2011, Pages 137-141

  Wallner, Lauren P ^a   Morgenstern, Hal ^a   McGree, Michaela E ^a   Jacobson, Debra J ^a   St Sauver, Jennifer L ^a   Jacobsen, Steven J ^a   Sarma, Aruna V ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; BLOOD LEVEL; BLOOD SAMPLING; CAUCASIAN; CONCENTRATION (PARAMETERS); DEMOGRAPHY; DISEASE ASSOCIATION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PHYSICIAN; PRIORITY JOURNAL; QUESTIONNAIRE; UNITED STATES;

ADULT; AGED; DIABETES MELLITUS, TYPE 2; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PROSTATE-SPECIFIC ANTIGEN; TIME FACTORS;

EID: 78650857644     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2010.07.516     Document Type: Article

References (31)

1. National Cancer Institute Estimated New Cases and Deaths of Prostate Cancer 2007
2. American Cancer Society Cancer Facts & Figures 2010
3. F.H. Schroder, J. Hugosson, M.J. Roobol, T.L. Tammela, S. Ciatto, and V. Nelen Screening and prostate-cancer mortality in a randomized European study N Engl J Med 360 2009 1320 1328
4. Centers for Disease Control and Prevention Health 2007 (*) (*) (*)
5. Division of N and Physical A Overweight and Obesity 2007
6. J.S. Kasper, and E. Giovannucci A meta-analysis of diabetes mellitus and the risk of prostate cancer Cancer Epidemiol Biomarkers Prev 15 2006 2056 2062 (Pubitemid 44877026)
7. S. Bonovas, K. Filioussi, and A. Tsantes Diabetes mellitus and risk of prostate cancer: a meta-analysis Diabetologia 47 2004 1071 1078
8. C. Rodriguez, A.V. Patel, A.M. Mondul, E.J. Jacobs, M.J. Thun, and E.E. Calle Diabetes and risk of prostate cancer in a prospective cohort of US men Am J Epidemiol 161 2005 147 152 (Pubitemid 40096789)
9. D.M. Werny, M. Saraiya, and E.W. Gregg Prostate-specific antigen values in diabetic and nondiabetic US men, 2001-02 Am J Epidemiol 164 2006 978 983
10. M. Fukui, M. Tanaka, M. Kadono, S. Imai, G. Hasegawa, and T. Yoshikawa Serum prostate-specific antigen levels in men with type 2 diabetes Diabetes Care 31 2008 930 931
11. H. Muller, E. Raum, D. Rothenbacher, C. Stegmaier, and H. Brenner Association of diabetes and body mass index with levels of prostate-specific antigen: implications for correction of prostate-specific antigen cutoff values? Cancer Epidemiol Biomarkers Prev 18 2009 1350 1356
12. J.L. Beebe-Dimmer, R.L. Dunn, A.V. Sarma, J.E. Montie, and K.A. Cooney Features of the metabolic syndrome and prostate cancer in African-American men Cancer 109 2007 875 881
13. J.H. Han, N.Y. Choi, S.H. Bang, O.J. Kwon, Y.W. Jin, and S.C. Myung Relationship between serum prostate-specific antigen levels and components of metabolic syndrome in healthy men Urology 72 2008 749 754 [Discussion:754-755]
14. S. Loeb, K.A. Roehl, B.T. Helfand, D. Kan, and W.J. Catalona Can prostate specific antigen velocity thresholds decrease insignificant prostate cancer detection? J Urol 183 2010 112 116
15. A.J. Vickers, T. Wolters, C.J. Savage, A.M. Cronin, M.F. O'Brien, and K. Pettersson Prostate-specific antigen velocity for Early detection of prostate cancer: result from a large, representative, population-based cohort Eur Urol 2009 10.1016/j.eururo.2009.07.047
16. S.J. Jacobsen, C.J. Girman, H.A. Guess, T. Rhodes, J.E. Oesterling, and M.M. Lieber Natural history of prostatism: longitudinal changes in voiding symptoms in community dwelling men J Urol 155 1996 595 600
17. S.J. Jacobsen, H.A. Guess, L. Panser, C.J. Girman, C.G. Chute, and J.E. Oesterling A population-based study of health care-seeking behavior for treatment of urinary symptoms The Olmsted County Study of Urinary symptoms and health status among men Arch Fam Med 2 1993 729 735
18. L.J. Melton 3rd History of the Rochester Epidemiology Project Mayo Clin Proc 71 1996 266 274
19. N. Parekh, Y. Lin, S. Marcella, A.K. Kant, and G. Lu-Yao Associations of lifestyle and physiologic factors with prostate-specific antigen concentrations: evidence from the National Health and Nutrition Examination Survey (2001-04) Cancer Epidemiol Biomarkers Prev 17 2008 2467 2472
20. B. Djavan, B. Bursa, C. Seitz, G. Soeregi, M. Remzi, and A. Basharkhah Insulin-like growth factor 1 (IGF-1), IGF-1 density, and IGF-1/PSA ratio for prostate cancer detection Urology 54 1999 603 606
21. B. Djavan, M. Waldert, C. Seitz, and M. Marberger Insulin-like growth factors and prostate cancer World J Urol 19 2001 225 233
22. K.M. Waters, B.E. Henderson, D.O. Stram, P. Wan, L.N. Kolonel, and C.A. Haiman Association of diabetes with prostate cancer risk in the multiethnic cohort Am J Epidemiol 169 2009 937 945
23. J.S. Kasper, Y. Liu, and E. Giovannucci Diabetes mellitus and risk of prostate cancer in the health professionals follow-up study Int J Cancer 124 2009 1398 1403
24. S. Bonovas, K. Filioussi, and N.M. Sitaras Statin use and the risk of prostate cancer: A metaanalysis of 6 randomized clinical trials and 13 observational studies Int J Cancer 123 2008 899 904
25. S.J. Freedland, and A.W. Partin Obesity and prostate cancer detection and progression Rev Urol 6 2004 214 216
26. S.J. Freedland, and E.A. Platz Obesity and prostate cancer: making sense out of apparently conflicting data Epidemiol Rev 29 2007 88 97
27. P.H. Gann, M.L. Daviglus, A.R. Dyer, and J. Stamler Heart rate and prostate cancer mortality: results of a prospective analysis Cancer Epidemiol Biomarkers Prev 4 1995 611 616
28. J.P. Burke, P. O'Brien, J. Ransom, P.J. Palumbo, E. Lydick, and B.P. Yawn Impact of Case ascertainment on recent trends in diabetes incidence in Rochester, Minnesota, American J Epidemiol 155 2002 859 865
29. K.M. Skinner, D.R. Miller, E. Lincoln, A. Lee, and L.E. Kazis Concordance between respondent self-reports and medical records for chronic conditions: experience from the Veterans Health Study J Ambul Care Manage 28 2005 102 110
30. F. El Fakiri, M.A. Bruijnzeels, and A.W. Hoes No evidence for marked ethnic differences in accuracy of self-reported diabetes, hypertension, and hypercholesterolemia J Clin Epidemiol 60 2007 1271 1279
31. N.M. Gades, D.J. Jacobson, M.E. McGree, M.M. Lieber, R.O. Roberts, and C.J. Girman Dropout in a longitudinal, cohort study of urologic disease in community men BMCMED Resour Methodol 6 2006 58